If it's universally recommended then obviously people are going to be getting the vaccine much more broadly.

I think people are coming to the realization that this is going to be a marathon that's going to be running for a period of time and [Merck is] unlikely to pay any money out over the next few years.

It's a potentially politically charged issue because you're talking about vaccinating people against sexually transmitted diseases when they're 12 or 13.

I think it's sort of a meaningless statement from their perspective and they're trying to grab victory out of this by taking a posture that makes them look altruistic, ... I also think they're trying to look like they're being good corporate citizens. Since Bristol has been investigated by just about every government agency, they have a lot to make up for in that regard.

The market is under-penetrated, that's for sure.

I wouldn't say [Prozac] is selling well, ... It's nice that they preserved $182 million from the Prozac franchise, but it was $2 billion, so it's not real meaningful for Lilly.